In 2015, Zhao et al. [28] suggested a potential role of CCR5 receptor in glioblastoma proliferation and invasion as CCR5 was over-expressed during glioma progression to glioblastoma, correlating with reduced progression-free and overall survival [28]. This evidence concerns the gene CCR5 and glioma.